Project I Test: Implementing HIV Testing in Opioid Treatment Programs

NARecruitingINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2026

Conditions
HIV/AIDSHepatitis CSubstance Use DisordersOpioid-use Disorder
Interventions
OTHER

Information Control

The OTPs assigned to this group will be provided access to the NIDA/SAMHSA Blending Initiative product for HIV rapid testing. Resources generated from the HIV rapid testing Blending Initiative product include a fact sheet, resource guide, marketing materials, and an Excel-based budgeting tool. In addition to the HIV-specific materials, the website provides opportunities for training, self-study progress, workshop, and distance learning. OTPs also will receive a link to the Anti-Retroviral Treatment and Access to Services (ARTAS) intervention training website which provides information and training courses. Sites also will receive a hard (or electronic) copy of the ARTAS implementation manual and information about the provision of HIV testing, linkage to care and PrEP.

OTHER

HIV and HCV Testing Practice Coaching Intervention

The practice coaches (PCs) will work with the program team a) to establish capabilities, reimbursement systems and/or partnerships necessary to support HIV and HCV testing and evidence--based linkage to care and b) to reduce barriers (e.g., staffing, training) to the implementation and sustained provision of HIV and HCV testing. Also, due to the expense of HCV treatment, and potentially more complicated mechanisms for linking HCV-positive patients to further evaluation and care which may take more time than anticipated, PCs will provide OTPs with basic education and motivation about the importance of HCV testing for reasons other than immediate curative treatment. Information on PrEP also will be provided. The intervention will occur over approximately 29 weeks (or 6 months).

OTHER

HIV Testing Practice Coaching Intervention

The practice coaches (PCs) will work with the programs a) to establish capabilities, reimbursement systems and/or partnerships necessary to support HIV testing and evidence-based linkage to care and b) to reduce barriers (e.g., staffing, training) to the implementation and sustained provision of HIV testing. Information on Pre-Exposure Prophylaxis (PrEP) also will be provided. The intervention will occur over approximately 29 weeks (or 6 months) consisting of four distinct evidence-based phases designed to establish competency in the implementation of organizational change towards establishing HIV testing outcomes among OTP clientele.

Trial Locations (1)

10032

RECRUITING

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

University of Miami

OTHER

collaborator

Boston Medical Center

OTHER

collaborator

Research Foundation for Mental Hygiene, Inc.

OTHER

collaborator

San Francisco Department of Public Health

OTHER_GOV

collaborator

New York University Abu Dhabi

UNKNOWN

lead

Columbia University

OTHER